Trademarkia Logo

Australia

AU$
Trademark Search
AEGLEA

View On IPO.GOV.AU

AEGLEA
Cancelled: Cancelled at the request of IB

Last updated on 12 Feb 2025

Owner Info

Aeglea BioTherapeutics, Inc.

805 Las Cimas Parkway, Suite 100

Austin TX 78746, UNITED STATES OF AMERICA

Serial Number

2201821 filed on 8 Jun 2021

Correspondent

Christopher M. Kindel Pirkey Barber PLLC

1801 East 6th Street, Suite 300,

Austin TX 78702,

UNITED STATES OF AMERICA

AEGLEA

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of rare genetic diseases; pharmaceutical preparations for the treatment of arginase 1 deficiency; pharma Read More

Class [042]
Scientific research in the fields of pharmaceuticals, biopharmaceuticals, medicine, biologics, biotherapeutics, biosimilars, enzyme replacement therap Read More

Mark Details

Serial Number

2201821

Registered On

8 Jun 2021

Renewal On

NA

Mark Type

WORD

Legal History

Show more

Status DateAction Taken
12th Feb 2025Status change to Voided
2th Jun 2023International Registration in Australia Protected After Adverse (No amendments) correspondence sent
1st Jun 2023International Registration in Australia Protected After Adverse (No amendments) correspondence sent
1st Jun 2023IP Right Registration Published
1st Jun 2023Status change to Registered/Protected
25th Mar 2023Application Accepted correspondence sent
24th Mar 2023Application Accepted correspondence sent
24th Mar 2023IP Right has been Examined
24th Mar 2023IP Right Acceptance Published
24th Mar 2023Status change to Accepted